GYNEMAT (0803.250.466): financials and annual accounts

GYNEMAT

Ixelles ·KBO/BCE: BE 0803.250.466

Line	2025	2024	2023
Balance sheet: assets
Total assets`20/58`	148,811	106,657	98,597
Fixed assets`21/28`	26,851	7,010	-
Tangible fixed assets`22/27`	26,851	7,010	-
Plant, machinery and equipment`23`	2,980	4,480	-
Furniture and vehicles`24`	23,871	2,530	-
Current assets`29/58`	121,960	99,647	98,597
Amounts receivable after more than one year`29`	19,592	-	-
Other amounts receivable`291`	19,592	-	-
Amounts receivable within one year`40/41`	57,481	34,299	74,852
Trade receivables`40`	35,762	30,000	73,847
Other amounts receivable`41`	21,719	4,299	1,005
Cash at bank and in hand`54/58`	41,129	65,349	23,745
Deferred charges and accrued income`490/1`	3,759	-	-
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	148,811	106,657	98,597
Equity`10/15`	112,244	71,562	77,894
Contributions`10/11`	3,000	3,000	3,000
Reserves`13`	30,000	-	-
Distributable reserves`133`	30,000	-	-
Profit (loss) carried forward`14`	79,244	68,562	74,894
Provisions and deferred taxes`16`	0	19,000	-
Provisions for liabilities and charges`160/5`	0	19,000	-
Other liabilities and charges`164/5`	0	19,000	-
Amounts payable`17/49`	36,566	16,095	20,702
Amounts payable after more than one year`17`	14,166	-	-
Financial debts`170/4`	14,166	-	-
Amounts payable within one year`42/48`	22,400	16,095	20,702
Current portion of amounts payable after more than one year`42`	8,160	-	-
Trade debts`44`	14,241	933	1,530
Suppliers`440/4`	14,241	933	1,530
Taxes, remuneration and social security`45`	0	3,979	19,173
Taxes`450/3`	0	3,979	19,173
Other amounts payable`47/48`	0	11,184	-
Income statement
Non-recurring operating income`76A`	72	-	-
Gross operating margin`9900`	61,672	36,457	94,083
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	5,351	107	-
Provisions for liabilities and charges: additions (uses and reversals)`635/8`	-19,000	19,000	-
Other operating charges`640/8`	6,559	20,000	-
Operating profit (loss)`9901`	68,762	-2,650	94,083
Financial income`75/76B`	662	91	0
Recurring financial income`75`	662	91	0
Financial charges`65/66B`	18,660	54	16
Recurring financial charges`65`	18,660	54	16
Profit (loss) for the period before taxes`9903`	50,764	-2,613	94,067
Income taxes`67/77`	10,082	3,719	19,173
Profit (loss) for the period`9904`	40,682	-6,332	74,894
Profit (loss) for the period to be appropriated`9905`	40,682	-6,332	74,894
Appropriation of the result
Profit (loss) to be appropriated`9906`	109,244	68,562	74,894
Profit (loss) brought forward from the previous period`14P`	68,562	74,894	-
Transfer to equity`691/2`	30,000	-	-
To other reserves`6921`	30,000	-	-
Document	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	31-07-2026	2026-00363559	PDF
31-12-2024	micro format	06-03-2025	2025-00044153	PDF
31-12-2023	micro format	12-07-2024	2024-00238389	PDF

Line	2025	2024	2023
EBITDA	74,113	-2,543	-
Cash flow	46,033	-6,226	-
Investment in fixed assets	26,569	7,116	-
Change in cash	-24,220	41,604	-
Working capital	99,560	83,552	77,894
Solvency	75.4%	67.1%	79.0%
Current ratio	5.44	6.19	4.76
Debt to equity	0.33	0.22	0.27
ROE	36.2%	-8.8%	96.1%
ROA	27.3%	-5.9%	76.0%
Interest coverage	3.97	-47.02	-

Item	2025	2024	2023
Tangible fixed assets	€26,569	€7,116	-
Depreciation and write-downs of the year	€5,351	€107	-

GYNEMAT

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency75.4%

Current ratio5.44

Return on assets27.3%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on GYNEMAT

Next steps